Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Method

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Gynecologic Oncology|October 26, 2024
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summaryKathleen N Moore, Domenica Lorusso, Ana Oaknin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 11, 2025
Heterogeneity and Scoring Reproducibility of Folate Receptor 1 Immunohistochemistry in High-grade Serous CarcinomaBrooke Liang, Troy B Tenney, Lucy Han, et al.
The New England Journal of Medicine|December 6, 2023
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian CancerKathleen N Moore, Antoine Angelergues, Gottfried E Konecny, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Gynecologic Oncology|October 26, 2024
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summaryKathleen N Moore, Domenica Lorusso, Ana Oaknin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 11, 2025
Heterogeneity and Scoring Reproducibility of Folate Receptor 1 Immunohistochemistry in High-grade Serous CarcinomaBrooke Liang, Troy B Tenney, Lucy Han, et al.
The New England Journal of Medicine|December 6, 2023
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian CancerKathleen N Moore, Antoine Angelergues, Gottfried E Konecny, et al.
Pageof 3